Circulating C reactive protein in osteoarthritis: A systematic review and meta-analysis

Annals of the Rheumatic Diseases

Volumn 74, Issue 4, 2015, Pages 703-710

  Jin, Xingzhong ^a   Beguerie, Julieta Ruiz ^b   Zhang, Weiya ^c   Blizzard, Leigh ^a   Otahal, Petr ^a   Jones, Graeme ^a   Ding, Changhai ^a,d,e  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSIDAD AUSTRAL   (Argentina)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d MONASH UNIVERSITY   (Australia)

^e ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ARTICLE; CINAHL; EMBASE; HUMAN; INFLAMMATION; INFORMATION RETRIEVAL; MEDLINE; META ANALYSIS (TOPIC); OSTEOARTHRITIS; PAIN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMATIC REVIEW; META ANALYSIS; METABOLISM;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HUMANS; INFLAMMATION; OSTEOARTHRITIS; PHENOTYPE;

EID: 84925682450     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204494     Document Type: Article

References (56)

1. Rainbow R, Ren W, Zeng L. Inflammation and Joint Tissue Interactions in OA: Implications for Potential Therapeutic Approaches. Arthritis 2012; 2012: 8.
2. Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone 2012; 51: 249-57.
3. Filkova M, Liskova M, Hulejova H, et al. Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis. Ann Rheum Dis 2009; 68: 295-6.
4. Lavigne P, Benderdour M, Lajeunesse D, et al. Expression of ICAM-1 by osteoblasts in healthy individuals and in patients suffering from osteoarthritis and osteoporosis. Bone 2004; 35: 463-70.
5. Otterness IG, Weiner E, Swindell AC, et al. An analysis of 14 molecular markers for monitoring osteoarthritis. Relationship of the markers to clinical end-points. Osteoarthritis Cartilage 2001; 9: 224-31.
6. Toncheva A, Remichkova M, Ikonomova K, et al. Inflammatory response in patients with active and inactive osteoarthritis. Rheumatol Int 2009; 29: 1197-203.
7. Calabro P, Chang DW, Willerson JT, et al. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: Linking obesity to vascular inflammation. J Am Coll Cardiol 2005; 46: 1112-13.
8. Montagne P, Laroche P, Cuillière ML, et al. Microparticle-enhanced nephelometric immunoassay for human C-reactive protein. J Clin Lab Anal 1992; 6: 24-9.
9. Loose L, de Oliveira R, Sipe J, et al. A possible systemic component of osteoarthritis: Elevated concentrations (by ELISA) of C-reactive protein in the serum of OA patients and modulataion by tenidap (abstr.). Arthritis Rheum 1996; 36 (Suppl): S166.
10. Pearle AD, Scanzello CR, George S, et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage 2007; 15: 516-23.
11. Stannus OP, Jones G, Blizzard L, et al. Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: A prospective cohort study. Ann Rheum Dis 2013; 72: 535-40.
12. Sturmer T, Brenner H, Koenig W, et al. Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis 2004; 63: 200-5.
13. Davis CR, Karl J, Granell R, et al. Can biochemical markers serve as surrogates for imaging in knee osteoarthritis? Arthritis Rheum 2007; 56: 4038-47.
14. Nevitt M, Felson D, Peterfy C, et al. Inflammation markers (CRP, TNF-Alpha, IL-6) are not associated with radiographic or MRI findings of knee OA in the elderly: The Health ABC Study [Abstract]. Arthritis Rheum 2002; 46(Suppl): S372-3.
15. Vlad SC, Neogi T, Aliabadi P, et al. No association between markers of inflammation and osteoarthritis of the hands and knees. J Rheumatol 2011; 38: 1665-70.
16. Scottish Intercollegiate Guidelines Network. SIGN filters for observational studies. Secondary SIGN filters for observational studies 2012. http://www.sign.ac.uk/methodology/filters.html#obs
17. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-Analyses. Secondary The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-Analyses. 2012. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp
18. Deeks JJ, Dinnes J, D'Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess 2003; 7: Iii-x, 1-173.
19. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-Analyses. BMJ 2003; 327: 557-60.
20. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-Analyses of controlled trials with binary endpoints. Stat Med 2006; 25: 3443-57.
21. Higgins JP, White IR, Anzures-Cabrera J. Meta-Analysis of skewed data: Combining results reported on log-Transformed or raw scales. Stat Med 2008; 27: 6072-92.
22. Otterness IG, Zimmerer RO, Swindell AC, et al. An examination of some molecular markers in blood and urine for discriminating patients with osteoarthritis from healthy individuals. Acta Orthopaedica 1995; 66: 148-50.
23. Golightly YM, Marshall SW, Kraus VB, et al. Biomarkers of incident radiographic knee osteoarthritis: Do they vary by chronic knee symptoms? Arthritis Rheum 2011; 63: 2276-83.
24. Bos SD, Suchiman HED, Kloppenburg M, et al. Allelic variation at the C-reactive protein gene associates to both hand osteoarthritis severity and serum high sensitive C-reactive protein levels in the GARP study. Ann Rheum Dis 2008; 67: 877-9.
25. Garnero P, Piperno M, Gineyts E, et al. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: Relations with disease activity and joint damage. Ann Rheum Dis 2001; 60: 619-26.
26. Hulejova H, Baresova V, Klezl Z, et al. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine 2007; 38: 151-6.
27. Hussein MR, Fathi NA, El-Din AME, et al. Alterations of the CD4(+), CD8 (+) T cell subsets, interleukins-1beta, IL-10, IL-17, tumor necrosis factor-Alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: Preliminary observations. Pathol Oncol Res 2008; 14: 321-8.
28. Melikoglu MA, Yildirim K, Senel K. Relationship between radiographic grading of osteoarthritis and serum beta-2 microglobulin. Ir J Med Sci 2009; 178: 151-4.
29. Punzi L, Ramonda R, Oliviero F, et al. Value of C reactive protein in the assessment of erosive osteoarthritis of the hand. Ann Rheum Dis 2005; 64: 955-7.
30. Otterness IG, Swindell AC, Zimmerer RO, et al. An analysis of 14 molecular markers for monitoring osteoarthritis: Segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis Cartilage 2000; 8: 180-5.
31. Sharif M, Elson CJ, Dieppe PA, et al. Elevated serum C-reactive protein levels in osteoarthritis. Br J Rheumatol 1997; 36: 140-1.
32. So AK, Varisco PA, Kemkes-Matthes B, et al. Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost 2003; 1: 2510-15.
33. Takahashi M, Naito K, Abe M, et al. Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 2004; 6: R208-12.
34. Brenner SS, Klotz U, Alscher DM, et al. Osteoarthritis of the knee-clinical assessments and inflammatory markers. Osteoarthritis Cartilage 2004; 12: 469-75.
35. Biochemical markers are associated with radiographic subtypes of osteoarthris (OA) in subjects with familial OA at multiple sites. The GARP study. 2006.
36. Chen HC, Shah S, Stabler TV, et al. Biomarkers associated with clinical phenotypes of hand osteoarthritis in a large multigenerational family: The CARRIAGE family study. Osteoarthritis Cartilage 2008; 16: 1054-9.
37. Sowers M, Jannausch M, Stein E, et al. C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthritis Cartilage 2002; 10: 595-601.
38. Wolfe F. The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip. J Rheumatol 1997; 24: 1486-8.
39. Engstrom G, Gerhardsson de Verdier M, Rollof J, et al. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthritis Cartilage 2009; 17: 168-73.
40. Garnero P, Mazieres B, Gueguen A, et al. Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: The ECHODIAH cohort. Journal of Rheumatology 2005; 32: 697-703.
41. Pearle AD, Scanzello CR, George S, et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage 2007; 15: 516-23.
42. Keenan RT, Swearingen CJ, Yazici Y. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients. Clin Exp Rheumatol 2008; 26: 814-19.
43. Conrozier T, Chappuis-Cellier C, Richard M, et al. Increased serum C-reactive protein levels by immunonephelometry in patients with rapidly destructive hip osteoarthritis. Revue du Rhumatisme (English Edition) 1998; 65: 759-65.
44. Kraus VB, Stabler TV, Luta G, et al. Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis. Osteoarthritis Cartilage 2007; 15: 966-71.
45. Spector TD, Hart DJ, Nandra D, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997; 40: 723-7.
46. Conrozier T, Carlier MC, Mathieu P, et al. Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: A cross sectional study. Ann Rheum Dis 2000; 59: 828-31.
47. Sturmer T, Brenner H, Koenig W, et al. Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis 2004; 63: 200-5.
48. Kerkhof HJ, Bierma-Zeinstra SM, Castano-Betancourt MC, et al. Serum C reactive protein levels and genetic variation in the CRP gene are not associated with the prevalence, incidence or progression of osteoarthritis independent of body mass index. Ann Rheum Dis 2010; 69: 1976-82.
49. Sharif M, Shepstone L, Elson CJ, et al. Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee. Ann Rheum Dis 2000; 59: 71-4.
50. Livshits G, Zhai G, Hart DJ, et al. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford Study. Arthritis Rheum 2009; 60: 2037-45.
51. Mazieres B, Garnero P, Gueguen A, et al. Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis 2006; 65: 354-9.
52. Gungen G, Ardic F, Fiotandikoglu G, et al. The effect of mud pack therapy on serum YKL-40 and hsCRP levels in patients with knee osteoarthritis. Rheumatol Int 2012; 32: 1235-44.
53. Lee YC, Lu B, Bathon JM, et al. Pain sensitivity and pain reactivity in osteoarthritis. Arthritis Care Res 2011; 63: 320-7.
54. Kao TW, Lu IS, Liao KC, et al. Associations between body mass index and serum levels of C-reactive protein. S Afr Med J 2009; 99: 326-30.
55. Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-5.
56. Choi J, Joseph L, Pilote L, et al. Obesity and C-reactive protein in various populations: A systematic review and meta-Analysis. Obesity Reviews 2013; 14: 232-44.